European patients' groups, set up to represent the interests of the subjects of medical procedures in their dealings with healthcare systems, insurance firms and drug companies are in many cases bankrolled by pharmaceutical firms, according to a new report.
Complicating the situation, many such groups working with and on the board of the European Medicines Agency - the very EU agency charged with evaluation of medicines in the bloc.
A fresh report from transparency watchdog Corpor...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? Login